Latest News for: rna

Edit

Fluorescent RNA sensor gets 10 times more sensitive for water safety

Phys Dot Org 18 May 2026
The answer is ROSALIND—a platform named after chemist Rosalind Franklin, and short for RNA Output Sensors Activated by Ligand Induction ... When ROSALIND detects a target chemical, it triggers the production of a fluorescent RNA molecule.
Edit

Hantavirus RNA can stay in semen for years, may offer lifelong immunity: What study reveals

Live Mint 17 May 2026
Amid the hantavirus outbreak on MV Hondius, several questions were asked, including its long-term impact and transmission through sex. Here's what past studies have revealed ....
Edit

Hidden small RNA in cholera bacterium helps determine whether it can infect humans

Phys Dot Org 17 May 2026
The researchers found that a small RNA embedded within another gene controls where cholera thrives, a discovery that could improve prediction and prevention strategies ... Small RNA variants have big consequences for colonization.
Edit

Single-molecule RNA mapping may reveal how shape shifts steer health and disease

Phys Dot Org 16 May 2026
RNA is best known for carrying genetic instructions from DNA to make proteins. However, RNA does more than act as a messenger ... Until now, studying these structures in detail has been difficult because RNA is highly flexible and dynamic.
Edit

RNA's first letter may shape antiviral alarms, with A outpacing G

Phys Dot Org 16 May 2026
"We are interested in how cells recognize harmless self RNA from RNA linked to infection or stress ... synthetic RNAs, cell-based immune assays, RNA sequencing, RNA pull-down coupled with mass ...
Edit

ASGCT 2026: GalNAc-conjugated RNA editing oligonucleotides achieve high potency in AATD models (Korro Bio Inc)

Public Technologies 15 May 2026
Editing RNA ... RNA Editing. Transiently Affecting an A-to-I Edit on RNA Using an Oligonucleotide. Non-viral intracellular delivery of Korro oligo designed to edit a specific adenosine on the target RNA ... Oligo-RNA duplex recruits adenosine ... Target RNA.
Edit

Hidden small RNA determines if cholera bacterium can infect humans

Citizen Tribune 14 May 2026
A small string of nucleic acids decides if the cholera bacterium can infect humans or live in the environment ....
Edit

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

PR Newswire 14 May 2026
Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence.
Edit

AIRNA Presents New Preclinical Data on AATD Therapeutic Candidate AIR-001 and Cardiometabolic RNA-Editing Programs at ASGCT (Forbion Capital Partners Management Services BV)

Public Technologies 13 May 2026
Together, the presentations demonstrate the potential of AIRNA's RNA-editing platform both to repair disease-causing variants and to introduce protective variants associated with human health.
Edit

EnPlusOne Biosciences Highlights Significant Advancements to its ezRNA™ Enzymatic RNA Synthesis Platform and Introduces Novel Modifications for Next-Generation RNA Therapeutics

Pharmiweb 12 May 2026
Lead of RNA Synthesis Ella Meyer will present “Pushing the Efficiency and Scale of Enzymatic RNA Synthesis” on May 13 at 4.45 pm at TIDES USA (May 11-14 at the Hynes Convention Center) ... EnPlusOne is enabling the future of RNA therapeutics.
Edit

EnPlusOne Biosciences Highlights Significant Advancements to its ezRNA™ Enzymatic RNA Synthesis Platform and Introduces Novel ...

Business Wire 12 May 2026
... progress on the enzymatic synthesis of RNA at two major industry conferences in Boston this month.
Edit

Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development

PR Newswire 12 May 2026
 ("Ribo", 06938.HK), a globally leading clinical-stage company in oligonucleotide therapeutics ... 03696.HK ... is a global biopharmaceutical company dedicated to the development and commercialization of small interfering RNA (siRNA) therapeutics ... .
×